It took a $13-million restructuring charge linked to downsizing at its head and regional offices to offset the impact of provincial drug-pricing reforms.It laid off some 120 to 130 employees during the most recent quarter, mostly from its head office, but also some home health-care employees.Adjusted net earnings per share, excluding the restructuring and other items, were 81 cents, up from 79 cen